Anti-inflammatory effects of daidzein on primary astroglial cell culture

Man Hai Liu, Yu Shan Lin, Shiow Yunn Sheu, Jui Sheng Sun

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Introduction: Alzheimer's disease is the common cause of dementia in old people. The pathological hallmarks of Alzheimer's disease include neuronal loss, deposition of amyloid-β, andInstitute of presence of neurofibrillary tangles. The endogenous steroid estrogen has been shown to affect neuronal growth, differentiation and survival, while isoflavones also have a neuroprotective effect on human cortical neurons. Daidzein, however, has a superior neuron-protective effect to other isoflavones. The present study is to determine whether daidzein is able to inhibit the production of pro-inflammatory mediators under amyloid-β and lipopolysaccharide stimulation. Materials and methods: Astrocyte cells were stimulated with amyloid-β or lipopolysaccharide in the absence and presence of diadzein. Nitric oxide released into the culture media was determined using the Griess reaction, and concentrations of IL-1, IL-6, TNF-α and estrogen receptor gene expression were measured by semi-quantitative real-time polymerase chain reaction assay. Results: Diadzein-treatment increases astrocyte cell counts and attains its maximal effect at the 10 -12M concentration. The addition of 20 μM amyloid-β or 10 -6 g/ml LPS can significantly decrease the viability of astrocytes, up-regulated IL-1, IL-6, TNF-α mRNA and estrogen receptor expression; in addition, 1-h daidzein pre-treatment can restore the decreased viability of astrocytes induced by amyloid-β or lipopolysaccharide as well as down-regulate their mRNA expression. Conclusions: It seems that this response is estrogen receptor-mediated. These results further increase the possibility that daidzein may have potential to ameliorate the inflammatory process and also alleviate the risk of Alzheimer's disease progression.

Original languageEnglish
Pages (from-to)123-134
Number of pages12
JournalNutritional Neuroscience
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 1 2009

Fingerprint

Primary Cell Culture
Amyloid
Anti-Inflammatory Agents
Astrocytes
Estrogen Receptors
Lipopolysaccharides
Alzheimer Disease
Isoflavones
Tumor Necrosis Factor Receptors
Interleukin-1
Interleukin-6 Receptors
Neurons
Messenger RNA
Neurofibrillary Tangles
Neuroprotective Agents
Culture Media
Dementia
Disease Progression
daidzein
Real-Time Polymerase Chain Reaction

Keywords

  • Amyloid beta-peptide
  • Diadzein
  • Lipopolysaccharide
  • Neuroprotective effect

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Neuroscience(all)

Cite this

Anti-inflammatory effects of daidzein on primary astroglial cell culture. / Liu, Man Hai; Lin, Yu Shan; Sheu, Shiow Yunn; Sun, Jui Sheng.

In: Nutritional Neuroscience, Vol. 12, No. 3, 01.06.2009, p. 123-134.

Research output: Contribution to journalArticle

Liu, Man Hai ; Lin, Yu Shan ; Sheu, Shiow Yunn ; Sun, Jui Sheng. / Anti-inflammatory effects of daidzein on primary astroglial cell culture. In: Nutritional Neuroscience. 2009 ; Vol. 12, No. 3. pp. 123-134.
@article{1634c636ba4f45d7b802ff8b99662eb7,
title = "Anti-inflammatory effects of daidzein on primary astroglial cell culture",
abstract = "Introduction: Alzheimer's disease is the common cause of dementia in old people. The pathological hallmarks of Alzheimer's disease include neuronal loss, deposition of amyloid-β, andInstitute of presence of neurofibrillary tangles. The endogenous steroid estrogen has been shown to affect neuronal growth, differentiation and survival, while isoflavones also have a neuroprotective effect on human cortical neurons. Daidzein, however, has a superior neuron-protective effect to other isoflavones. The present study is to determine whether daidzein is able to inhibit the production of pro-inflammatory mediators under amyloid-β and lipopolysaccharide stimulation. Materials and methods: Astrocyte cells were stimulated with amyloid-β or lipopolysaccharide in the absence and presence of diadzein. Nitric oxide released into the culture media was determined using the Griess reaction, and concentrations of IL-1, IL-6, TNF-α and estrogen receptor gene expression were measured by semi-quantitative real-time polymerase chain reaction assay. Results: Diadzein-treatment increases astrocyte cell counts and attains its maximal effect at the 10 -12M concentration. The addition of 20 μM amyloid-β or 10 -6 g/ml LPS can significantly decrease the viability of astrocytes, up-regulated IL-1, IL-6, TNF-α mRNA and estrogen receptor expression; in addition, 1-h daidzein pre-treatment can restore the decreased viability of astrocytes induced by amyloid-β or lipopolysaccharide as well as down-regulate their mRNA expression. Conclusions: It seems that this response is estrogen receptor-mediated. These results further increase the possibility that daidzein may have potential to ameliorate the inflammatory process and also alleviate the risk of Alzheimer's disease progression.",
keywords = "Amyloid beta-peptide, Diadzein, Lipopolysaccharide, Neuroprotective effect",
author = "Liu, {Man Hai} and Lin, {Yu Shan} and Sheu, {Shiow Yunn} and Sun, {Jui Sheng}",
year = "2009",
month = "6",
day = "1",
doi = "10.1179/147683009X423274",
language = "English",
volume = "12",
pages = "123--134",
journal = "Nutritional Neuroscience",
issn = "1028-415X",
publisher = "Taylor & Francis",
number = "3",

}

TY - JOUR

T1 - Anti-inflammatory effects of daidzein on primary astroglial cell culture

AU - Liu, Man Hai

AU - Lin, Yu Shan

AU - Sheu, Shiow Yunn

AU - Sun, Jui Sheng

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Introduction: Alzheimer's disease is the common cause of dementia in old people. The pathological hallmarks of Alzheimer's disease include neuronal loss, deposition of amyloid-β, andInstitute of presence of neurofibrillary tangles. The endogenous steroid estrogen has been shown to affect neuronal growth, differentiation and survival, while isoflavones also have a neuroprotective effect on human cortical neurons. Daidzein, however, has a superior neuron-protective effect to other isoflavones. The present study is to determine whether daidzein is able to inhibit the production of pro-inflammatory mediators under amyloid-β and lipopolysaccharide stimulation. Materials and methods: Astrocyte cells were stimulated with amyloid-β or lipopolysaccharide in the absence and presence of diadzein. Nitric oxide released into the culture media was determined using the Griess reaction, and concentrations of IL-1, IL-6, TNF-α and estrogen receptor gene expression were measured by semi-quantitative real-time polymerase chain reaction assay. Results: Diadzein-treatment increases astrocyte cell counts and attains its maximal effect at the 10 -12M concentration. The addition of 20 μM amyloid-β or 10 -6 g/ml LPS can significantly decrease the viability of astrocytes, up-regulated IL-1, IL-6, TNF-α mRNA and estrogen receptor expression; in addition, 1-h daidzein pre-treatment can restore the decreased viability of astrocytes induced by amyloid-β or lipopolysaccharide as well as down-regulate their mRNA expression. Conclusions: It seems that this response is estrogen receptor-mediated. These results further increase the possibility that daidzein may have potential to ameliorate the inflammatory process and also alleviate the risk of Alzheimer's disease progression.

AB - Introduction: Alzheimer's disease is the common cause of dementia in old people. The pathological hallmarks of Alzheimer's disease include neuronal loss, deposition of amyloid-β, andInstitute of presence of neurofibrillary tangles. The endogenous steroid estrogen has been shown to affect neuronal growth, differentiation and survival, while isoflavones also have a neuroprotective effect on human cortical neurons. Daidzein, however, has a superior neuron-protective effect to other isoflavones. The present study is to determine whether daidzein is able to inhibit the production of pro-inflammatory mediators under amyloid-β and lipopolysaccharide stimulation. Materials and methods: Astrocyte cells were stimulated with amyloid-β or lipopolysaccharide in the absence and presence of diadzein. Nitric oxide released into the culture media was determined using the Griess reaction, and concentrations of IL-1, IL-6, TNF-α and estrogen receptor gene expression were measured by semi-quantitative real-time polymerase chain reaction assay. Results: Diadzein-treatment increases astrocyte cell counts and attains its maximal effect at the 10 -12M concentration. The addition of 20 μM amyloid-β or 10 -6 g/ml LPS can significantly decrease the viability of astrocytes, up-regulated IL-1, IL-6, TNF-α mRNA and estrogen receptor expression; in addition, 1-h daidzein pre-treatment can restore the decreased viability of astrocytes induced by amyloid-β or lipopolysaccharide as well as down-regulate their mRNA expression. Conclusions: It seems that this response is estrogen receptor-mediated. These results further increase the possibility that daidzein may have potential to ameliorate the inflammatory process and also alleviate the risk of Alzheimer's disease progression.

KW - Amyloid beta-peptide

KW - Diadzein

KW - Lipopolysaccharide

KW - Neuroprotective effect

UR - http://www.scopus.com/inward/record.url?scp=66349117037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349117037&partnerID=8YFLogxK

U2 - 10.1179/147683009X423274

DO - 10.1179/147683009X423274

M3 - Article

C2 - 19356315

AN - SCOPUS:66349117037

VL - 12

SP - 123

EP - 134

JO - Nutritional Neuroscience

JF - Nutritional Neuroscience

SN - 1028-415X

IS - 3

ER -